UA98756C2 - Антитело, которое связывается с cd38, для лечения заболевания, опосредованного cd38 - Google Patents

Антитело, которое связывается с cd38, для лечения заболевания, опосредованного cd38

Info

Publication number
UA98756C2
UA98756C2 UAA200711639A UAA200711639A UA98756C2 UA 98756 C2 UA98756 C2 UA 98756C2 UA A200711639 A UAA200711639 A UA A200711639A UA A200711639 A UAA200711639 A UA A200711639A UA 98756 C2 UA98756 C2 UA 98756C2
Authority
UA
Ukraine
Prior art keywords
treatment
mediated disease
binding antibody
antibody
disease
Prior art date
Application number
UAA200711639A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Мишель Де Верс
Иво Граус
Юдит Опринс
Пауль Паррен Паррен
Ян Ван Де Винкел
Мартин Ван Вюгт
Original Assignee
Генмаб А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Генмаб А/С filed Critical Генмаб А/С
Priority to UAA201204050A priority Critical patent/UA116520C2/uk
Publication of UA98756C2 publication Critical patent/UA98756C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
UAA200711639A 2005-03-23 2006-03-23 Антитело, которое связывается с cd38, для лечения заболевания, опосредованного cd38 UA98756C2 (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201204050A UA116520C2 (uk) 2005-03-23 2006-03-23 Антитіло проти cd38 для лікування множинної мієломи

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200500429 2005-03-23

Publications (1)

Publication Number Publication Date
UA98756C2 true UA98756C2 (ru) 2012-06-25

Family

ID=50644285

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA201204050A UA116520C2 (uk) 2005-03-23 2006-03-23 Антитіло проти cd38 для лікування множинної мієломи
UAA200711639A UA98756C2 (ru) 2005-03-23 2006-03-23 Антитело, которое связывается с cd38, для лечения заболевания, опосредованного cd38

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UAA201204050A UA116520C2 (uk) 2005-03-23 2006-03-23 Антитіло проти cd38 для лікування множинної мієломи

Country Status (12)

Country Link
KR (1) KR20140033240A (OSRAM)
BE (1) BE2017C062I2 (OSRAM)
DK (1) DK1866338T3 (OSRAM)
ES (2) ES2644982T3 (OSRAM)
HU (2) HUE030783T2 (OSRAM)
LT (2) LT1866338T (OSRAM)
NZ (2) NZ625944A (OSRAM)
PL (1) PL1866338T3 (OSRAM)
PT (2) PT2567976T (OSRAM)
RS (1) RS55442B1 (OSRAM)
SG (1) SG10201610317VA (OSRAM)
UA (2) UA116520C2 (OSRAM)

Also Published As

Publication number Publication date
RS55442B1 (sr) 2017-04-28
LT1866338T (lt) 2017-01-25
ES2644982T3 (es) 2017-12-01
SG10201610317VA (en) 2017-02-27
PT2567976T (pt) 2017-10-19
UA116520C2 (uk) 2018-04-10
DK1866338T3 (da) 2017-01-02
HUE030783T2 (en) 2017-06-28
HUE034962T2 (en) 2018-03-28
PT1866338T (pt) 2016-12-14
NZ625944A (en) 2016-01-29
ES2606762T3 (es) 2017-03-27
PL1866338T3 (pl) 2017-04-28
KR20140033240A (ko) 2014-03-17
BE2017C062I2 (OSRAM) 2025-12-03
LT2567976T (lt) 2017-12-11
NZ600059A (en) 2016-01-29

Similar Documents

Publication Publication Date Title
EA200702053A1 (ru) Антитела против cd38 для лечения множественной миеломы
EA200801842A1 (ru) Антитела против бета-амилоидного пептида
EA200800355A1 (ru) Нейтрализующие антитела человека против b7rp1
UA109633C2 (uk) Антитіло людини проти тканинного фактора
DK1951759T3 (da) Anti-EGFR-antistoffer
EA200702064A1 (ru) Новое анти-plgf антитело
EA201170590A1 (ru) Ингибиторы рецептора фактора роста фибробластов-3 (fgfr-3) и способы лечения
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
EA200970113A1 (ru) Бензофуро- и бензотиенопиримидиновые модуляторы гистаминового рецептора н
ATE502052T1 (de) Monoklonale antikörper gegen den humanen anti- müllerian-hormonrezeptor vom typ ii (amhr-ii)
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
EA200971077A1 (ru) Гетероциклические модуляторы киназы
UA106194C2 (ru) Диагностика и лечение рака с применением антитела к ereg
EA200970262A1 (ru) Композиции и способы, относящиеся к антителам к глюкагоновым рецепторам
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
EA201070822A1 (ru) Доставка антител посредством модульного домена распознавания
EA200801509A1 (ru) Человеческие моноклональные антитела к протеинтирозинкиназе 7 ( ptk7) и способы применения антител против ptk7
EA200702048A1 (ru) Фармакокинетически улучшенные соединения
EA201290849A1 (ru) Оптимизированные моноклональные антитела против ингибитора пути тканевого фактора (tfpi)
MX2007011545A (es) Combinaciones para el tratamiento de cancer que comprenden el anticuerpo anti-egfr e inhibidores de vegfr.
UA113623C2 (uk) Моноклональне антитіло проти інгібітору шляху тканинного фактора (tfpi)
EA200900767A1 (ru) Антагонистические антитела против ephb3
EA201170425A1 (ru) Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения
ATE517920T1 (de) Humanisierte antikörper gegen interferon-alpha- rezeptor-1 (ifnar-1)